03.21.2022
Four Key Considerations to Help Prepare for the Next Public Health Threat
As a CDMO, Emergent has been working for more than two decades to develop, manufacture and deliver protections against public...
Learn more about Emergent CDMO’s work and the many milestones we’ve reached in our news release archive below. If you’re a media representative, please feel free to contact our media relations office at mediarelations@ebsi.com.
Should you be interested in learning more about Emergent BioSolutions Inc.(NYSE: EBS), please visit our corporate Newsroom.
03.21.2022
As a CDMO, Emergent has been working for more than two decades to develop, manufacture and deliver protections against public...
03.14.2022
Emergent is pleased to announce the addition of two senior leaders to its CDMO and Quality & Compliance organizations.
03.11.2022
Dino Muzzin, senior vice president of manufacturing operations at Emergent BioSolutions recently shared his insights with Pharma...
07.23.2021
With the expansion of our viral drug product manufacturing facility in Rockville, Maryland well underway, we have begun...
05.12.2021
Our drug product manufacturing facility in Rockville, Maryland is undergoing an expansion that will soon house a...
02.13.2021
Emergent has entered into a new CDMO agreement with Providence Therapeutics to provide fill/finish drug product manufacturing...
01.25.2021
GAITHERSBURG, MD. and BURLINGAME, CA. – Jan. 25, 2021 — Emergent BioSolutions Inc. (NYSE:EBS) (Emergent) and Humanigen, Inc. ...
10.01.2020
Emergent BioSolutions, a Wells Fargo Corporate & Investment Banking customer since 2011, helps governments respond to health...
09.01.2020
“Emergent has a long, successful history of working with the US government to develop, manufacture, and deliver safe and...
07.07.2020
Read the latest news coverage of Emergent's insights and involvement in the fight against COVID-19. Last Updated: Thursday,...